Article information
Article
These are the options to access the full texts of the publication Revista Clínica Española (English Edition)
Member
Si es usted socio de FESEMI siga los siguientes pasos:
Diríjase desde aquí a la web de la >>>https://www.fesemi.org/publicaciones/revista-clinica/noticias<<< e inicie sesión mediante el formulario que se encuentra en la barra superior, pulsando sobre el candado.
Deslice el cursor hacia abajo hasta la sección "PUBLICACIONES" y pinche en "Revista Clínica Española":
>>>https://www.fesemi.org/publicaciones/revista-clinica/noticias<<<
Purchase
Bibliografía
[1]
N. Conrad, A. Judge, D. Canoy, J. Tran, A.C. Pinho-Gomes, E.R.C. Millett, et al.
Temporal trends and patterns in mortality after incident heart failure: A longitudinal analysis of 86000 individuals.
JAMA Cardiol, (2019),
[2]
P. Ponikowski, A.A. Voors, S.D. Anker, H. Bueno, J.G.F. Cleland, A.J.S. Coats, et al.
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Eur J Heart Fail., 18 (2016), pp. 891-975
[3]
W.B. Kannel.
Incidence and epidemiology of heart failure.
Heart Fail Rev., 5 (2000), pp. 167-173
[4]
D. Pascual-Figal, A. Bayes-Genis.
The misperception of”stable” heart failure.
Eur J Heart Fail., 20 (2018), pp. 1375-1378
[5]
V. Barrios, C. Escobar, C. Ortiz Cortés, J. Cosín Sales, D.A. Pascual Figa, X. Garcia-Moll.
Manejo de los pacientes con insuficiencia cardiaca atendidos en la consulta de cardiología: Estudio IC-BERG.
Rev Clin Esp., 220 (2020), pp. 339-349
[6]
R. Boulkedid, H. Abdoul, M. Loustau, O. Sibony, C. Alberti.
Using and reporting the Delphi method for selecting healthcare quality indicators: A systematic review.
PLoS One., 6 (2011), pp. e20476
[7]
C.W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D.E. Casey Jr., M.M. Colvin, et al.
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of Amer.
J Am Coll Cardiol., 70 (2017), pp. 776-803
[8]
F.-J. Ruiz-Laiglesia, M. Sánchez-Marteles, J.-I. Pérez-Calvo, F. Formiga, J.A. Bartolomé-Satué, A. Armengou-Arxé, et al.
Comorbidity in heart failure. Results of the Spanish RICA Registry.
QJM., 107 (2014), pp. 989-994
[9]
K.M. Goode, S. Nabb, J.G. Cleland, A.L. Clark.
A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic.
J Card Fail, 14 (2008), pp. 379-387
[10]
J.L. Januzzi, R. van Kimmenade, J. Lainchbury, A. Bayes-Genis, J. Ordonez-Llanos, M. Santalo-Bel, et al.
NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: The International Collaborative of NT-proBNP Study.
Eur Heart J., 27 (2006), pp. 330-337
[11]
J.L. Januzzi Jr., A.A. Chen-Tournoux, R.H. Christenson, G. Doros, J.E. Hollander, P.D. Levy, ICON-RELOADED Investigators, et al.
N-terminal pro-B-type natriuretic peptide in the emergency department: The ICON-RELOADED Study.
J Am Coll Cardiol, 71 (2018), pp. 1191-1200
[12]
R. Spevack, M. al Shukairi, D. Jayaraman, J. Dankoff, L. Rudski, J. Lipes.
Serial lung and IVC ultrasound in the assessment of congestive heart failure.
Crit Ultrasound J., 9 (2017), pp. 7
[13]
C. Josa-Laorden, I. Giménez-López, J. Rubio-Gracia, F. Ruiz-Laiglesia, V. Garcés-Horna, J.I. Pérez-Calvo.
Valor pronóstico de la medición del diámetro y colapso inspiratorio de la vena cava inferior en la insuficiencia cardiaca aguda.
Rev Clínica Española [Internet]., 216 (2016), pp. 183-190
[14]
N. Girerd, M.F. Seronde, S. Coiro, T. Chouihed, P. Bilbault, F. Braun, INI-CRCT Great Network, and the EF-HF Group, et al.
Integrative assessment of congestion in heart failure throughout the patient journey.
JACC Heart Fail., 6 (2018), pp. 273-285
[15]
J. Núñez, E. Núñez, L. Consuegra, J. Sanchis, V. Bodí, A. Martínez-Brotons, et al.
Carbohydrate antigen 125: An emerging prognostic risk factor in acute heart failure?.
Heart., 93 (2007), pp. 716-721
[16]
J. Rubio-Gracia, B.G. Demissei, J.M. ter Maaten, J.G. Cleland, C.M. O’Connor, M. Metra, et al.
Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure.
Int J Cardiol., 258 (2018), pp. 185-191
[17]
A.P. Ambrosy, P.S. Pang, S. Khan, M.A. Konstam, G.C. Fonarow, B. Traver, et al.
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: Findings from the EVEREST trial.
Eur Heart J., 34 (2013), pp. 835-843
[18]
E. Picano, P.A. Pellikka.
Ultrasound of extravascular lung water: A new standard for pulmonary congestion.
Eur Heart J., 37 (2016), pp. 2097-2104
[19]
J. Curbelo, P. Rodriguez-Cortes, M. Aguilera, P. Gil-Martinez, D. Martín, C. Suarez Fernandez.
Comparison between inferior vena cava ultrasound, lung ultrasound, bioelectric impedance analysis, and natriuretic peptides in chronic heart failure.
Curr Med Res Opin., 35 (2019), pp. 705-713
[20]
B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, et al.
The effect of spironolactone on morbidity and mortality in patients with severe heart failure.
N Engl J Med, 341 (1999), pp. 709-717
[21]
D.N. Juurlink, M.M. Mamdani, D.S. Lee, A. Kopp, P.C. Austin, A. Laupacis, et al.
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
N Engl J Med., 351 (2004), pp. 543-551
[22]
J.J.V. McMurray, M. Packer, A.S. Desai, J. Gong, M.P. Lefkowitz, A.R. Rizkala, et al.
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
N Engl J Med., 371 (2014), pp. 993-1004
